. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Bone Density Conservation Agents/administration & dosageBone Density Conservation Agents/adverse effectsBone Density Conservation Agents/pharmacokineticsDiphosphonates/administration & dosageDiphosphonates/adverse effectsDiphosphonates/pharmacokineticsDrug Administration ScheduleFemaleFractures, Bone/etiologyFractures, Bone/prevention & controlHumansImidazoles/administration & dosageImidazoles/adverse effectsImidazoles/pharmacokineticsInfusions, IntravenousOsteoporosis, Postmenopausal/complicationsOsteoporosis, Postmenopausal/drug therapyTreatment OutcomeZoledronic Acid
Substances: See more » Bone Density Conservation AgentsDiphosphonatesImidazolesZoledronic Acid
Year: 2007 PMID: 17975523
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN: 0025-732X Impact factor: 1.909